Peripheral PD-1+CD56+T-cell frequencies correlate with outcome in stage IV melanoma under PD-1 blockade

Bochem, J; Zelba, H; Amaral, T; Spreuer, J; Soffel, D; Eigentler, T; Wagner, NB; Uslu, U; Terheyden, P; Meier, F; Garbe, C; Pawelec, G; Weide, B; Wistuba-Hamprecht, K

Wistuba-Hamprecht, K (reprint author), Univ Med Ctr, Dept Dermatol, Tubingen, Germany.

PLOS ONE, 2019; 14 (8):

Abstract

Immune checkpoint blockade with anti-PD-1 antibodies is showing great promise for patients with metastatic melanoma and other malignancies, but despit......

Full Text Link